Related Experiment Video

Updated: Aug 19, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

[Impact of oncologic therapeutic concepts 2004]

Christoph C Zielinski1

  • 1Klinische Abteilung for Onkologie, Univ.-Klinik für Innere Medizin I, Medizinische Universität Wien, Wien, Osterreich. christoph.zielinski@meduniwien.ac.at

Acta Medica Austriaca
|March 1, 2005
PubMed

Insights

Recent advances in cancer therapy target specific molecular pathways, but tumor growth adaptation limits effectiveness. Current methods lack the precision for constant tumor inhibition, highlighting the need for improved therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Context:

  • Therapeutic strategies in oncology have evolved, focusing on molecular targets like cell surface receptors and signal transduction pathways.
  • Recent advancements utilize experimental findings for clinical applications, aiming for more specific cancer treatments.
  • Despite progress, substantial influence on many oncologic ailments remains limited.

Purpose:

  • To review the evolution of therapeutic concepts in oncology.
  • To discuss the specificity of emerging therapeutic targets.
  • To highlight the challenges in achieving constant tumor growth inhibition.

Summary:

  • Therapeutic concepts in oncology have shifted towards molecular targets, including receptor modulation, signal transduction interference, oncogene inactivation, tumor suppressor gene activation, apoptosis induction, and peptide degradation inhibition.
  • While therapeutic targets have become more specific, clinical success is often limited due to the adaptive nature of tumor growth.
  • The effectiveness of targeted therapies, such as Gefitinib, is constrained by the dynamic biological mechanisms of tumors, indicating current methodologies are not precise enough for sustained tumor control.

Impact:

  • This review underscores the gap between targeted therapy development and clinical outcomes in oncology.
  • It emphasizes the need for more precise methodologies to overcome tumor adaptation and achieve sustained inhibition of cancer growth.
  • The findings suggest future research should focus on understanding and counteracting tumor plasticity for more effective cancer treatment.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...